Tokyo Tape
Sign in
← Nissan Chemical Corporatiom

Quarterly report · Q2

4021.TEDINET S100S7OI
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥105.7bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥228.1bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥109.5bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥24.1bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥28.2bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥26.2bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥55.8bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥32.0bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥26.8bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥32.0bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥19.5bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥41.1bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥23.7bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥19.7bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥24.1bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥292.1bnat 2023-09-30Cons.Assets
Total assets¥298.7bnat 2023-03-31Cons.Assets
Total assets¥280.2bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥66.2bnat 2023-09-30Cons.Liabilities
Total liabilities¥77.2bnat 2023-03-31Cons.Liabilities
Net assets / equity¥225.9bnat 2023-09-30Cons.Net assets
Net assets / equity¥221.5bnat 2023-03-31Cons.Net assets
Net assets / equity¥219.4bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥21.2bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥29.6bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥21.2bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥29.6bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥43.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥34.7bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥36.0bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥35.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥43.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥8.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥19.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥9.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥36.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥25.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥29.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥139.552023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥52.082023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥291.362022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥167.742022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥69.582022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio76.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio73.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 63
SegmentItemPeriodValue
Otherother segmentsrevenue2023-04-01 → 2023-09-30¥12.3bn
Otherother segmentsrevenue external2023-04-01 → 2023-09-30¥4.7bn
Otherother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥7.6bn
Otherother segmentssegment profit2023-04-01 → 2023-09-30¥158m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥52.6bn
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-09-30−¥13.4bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥39.2bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥2.3bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥35.3bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥29.5bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥5.8bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥11.6bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥17.9bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥11.9bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥6.0bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentsegment profit2023-04-01 → 2023-09-30−¥86m
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentrevenue2023-04-01 → 2023-09-30¥40.5bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentrevenue external2023-04-01 → 2023-09-30¥32.9bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥7.7bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentsegment profit2023-04-01 → 2023-09-30¥11.1bn
jpcrp040300-q2r_E00759-000Healthcarereportable segmentrevenue2023-04-01 → 2023-09-30¥3.5bn
jpcrp040300-q2r_E00759-000Healthcarereportable segmentrevenue external2023-04-01 → 2023-09-30¥3.5bn
jpcrp040300-q2r_E00759-000Healthcarereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥57m
jpcrp040300-q2r_E00759-000Healthcarereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.8bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentrevenue2023-04-01 → 2023-09-30¥48.8bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentrevenue external2023-04-01 → 2023-09-30¥36.6bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥12.2bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥158.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥119.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥39.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥26.4bn
Otherother segmentsrevenue2022-04-01 → 2022-09-30¥12.4bn
Otherother segmentsrevenue external2022-04-01 → 2022-09-30¥5.3bn
Otherother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥7.2bn
Otherother segmentssegment profit2022-04-01 → 2022-09-30¥100m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥51.3bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-09-30−¥14.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥36.9bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥2.3bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥35.7bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥31.2bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4.5bn
jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥12.1bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥19.8bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥13.7bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥6.0bn
jpcrp040300-q2r_E00759-000Chemical Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentrevenue2022-04-01 → 2022-09-30¥42.0bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentrevenue external2022-04-01 → 2022-09-30¥34.0bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥8.0bn
jpcrp040300-q2r_E00759-000Functional Materialsreportable segmentsegment profit2022-04-01 → 2022-09-30¥13.9bn
jpcrp040300-q2r_E00759-000Healthcarereportable segmentrevenue2022-04-01 → 2022-09-30¥3.2bn
jpcrp040300-q2r_E00759-000Healthcarereportable segmentrevenue external2022-04-01 → 2022-09-30¥3.2bn
jpcrp040300-q2r_E00759-000Healthcarereportable segmentsegment profit2022-04-01 → 2022-09-30¥1.5bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentrevenue2022-04-01 → 2022-09-30¥47.6bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentrevenue external2022-04-01 → 2022-09-30¥36.5bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥11.1bn
jpcrp040300-q2r_E00759-000Wholesalereportable segmentsegment profit2022-04-01 → 2022-09-30¥2.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥160.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥123.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥36.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥30.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 566
ItemContextValueUnit
Other noeCurrentYTDDuration139000000JPY
Non operating expensesPrior1YTDDuration600000000JPY
Non operating expensesCurrentYTDDuration953000000JPY
Ordinary incomePrior1YTDDuration31986000000JPY
Ordinary incomeCurrentYTDDuration26197000000JPY
Gain on sales of investment securities eiPrior1YTDDuration－JPY
Gain on sales of investment securities eiCurrentYTDDuration603000000JPY
Extraordinary incomePrior1YTDDuration－JPY
Extraordinary incomeCurrentYTDDuration603000000JPY
Extraordinary lossPrior1YTDDuration－JPY
Extraordinary lossCurrentYTDDuration－JPY
Income before income taxesPrior1YTDDuration31986000000JPY
Income before income taxesCurrentYTDDuration26801000000JPY
Income taxes currentPrior1YTDDuration7757000000JPY
Income taxes currentCurrentYTDDuration6806000000JPY
Income taxes deferredPrior1YTDDuration178000000JPY
Income taxes deferredCurrentYTDDuration313000000JPY
Income taxesPrior1YTDDuration7935000000JPY
Income taxesCurrentYTDDuration7119000000JPY
Profit lossPrior1YTDDuration24051000000JPY
Profit lossCurrentYTDDuration19682000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration367000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration184000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration23684000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration19497000000JPY
Profit lossPrior1YTDDuration24051000000JPY
Profit lossCurrentYTDDuration19682000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration365000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration586000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration944000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration2321000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration358000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-10000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration0JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration-0JPY
Other comprehensive incomePrior1YTDDuration1669000000JPY
Other comprehensive incomeCurrentYTDDuration2896000000JPY
Comprehensive incomePrior1YTDDuration25721000000JPY
Comprehensive incomeCurrentYTDDuration22578000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration25213000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration22140000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration507000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration437000000JPY
Income before income taxesPrior1YTDDuration31986000000JPY
Income before income taxesCurrentYTDDuration26801000000JPY
Depreciation and amortization ope cfPrior1YTDDuration5071000000JPY
Depreciation and amortization ope cfCurrentYTDDuration5829000000JPY
Amortization of goodwill ope cfPrior1YTDDuration50000000JPY
Amortization of goodwill ope cfCurrentYTDDuration50000000JPY
Interest and dividends income ope cfPrior1YTDDuration-446000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass